On Autism’s Trail
A new microarray that can simultaneously detect 500,000 or more specific genetic variations, covering almost every gene in the genome, will provide better insights into the complex genetic bases of many illnesses. Using the chip from Santa Clara, CA-based Affymetrix (a similar one is made by San Diego-based Illumina), researchers worldwide are seeking genetic causes of diseases such as autism, diabetes, and Alzheimer’s. Below is a sampling of these efforts. Emily Singer
Disease
U.S. sufferers
Status
Autism
1 million to 1.5 million
Genetic data from 3,700 people with autism are now being analyzed.
Alzheimer’s
4.5 million
Genetic data have been collected from 1,645 Alzheimer’s patients. Results from analysis are expected late this year or in early 2007.
Type 1 and type 2
diabetes
20.7 million
Early results from a study of 2,000 sufferers of each diabetes type are expected by early 2007.
Hypertension
65 million
Early results from a study of 2,000 sufferers are expected by early 2007.
Keep Reading
Most Popular
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
The problem with plug-in hybrids? Their drivers.
Plug-in hybrids are often sold as a transition to EVs, but new data from Europe shows we’re still underestimating the emissions they produce.
Sam Altman says helpful agents are poised to become AI’s killer function
Open AI’s CEO says we won’t need new hardware or lots more training data to get there.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.